Opposite_JJ
effects_NNS
of_IN
the_DT
acute_JJ
promyelocytic_JJ
leukemia_NN
PML-retinoic_JJ
acid_NN
receptor_NN
alpha_NN
-LRB-_-LRB-
RAR_NN
alpha_NN
-RRB-_-RRB-
and_CC
PLZF-RAR_NN
alpha_NN
fusion_NN
proteins_NNS
on_IN
retinoic_JJ
acid_NN
signalling_NN
._.

Fusion_NN
proteins_NNS
involving_VBG
the_DT
retinoic_JJ
acid_NN
receptor_NN
alpha_NN
-LRB-_-LRB-
RAR_NN
alpha_NN
-RRB-_-RRB-
and_CC
the_DT
PML_NN
or_CC
PLZF_NN
nuclear_JJ
protein_NN
are_VBP
the_DT
genetic_JJ
markers_NNS
of_IN
acute_JJ
promyelocytic_JJ
leukemias_NNS
-LRB-_-LRB-
APLs_NNS
-RRB-_-RRB-
._.

APLs_NNS
with_IN
the_DT
PML-RAR_NN
alpha_NN
or_CC
the_DT
PLZF-RAR_NN
alpha_NN
fusion_NN
protein_NN
are_VBP
phenotypically_RB
indistinguishable_JJ
except_IN
that_IN
they_PRP
differ_VBP
in_IN
their_PRP$
sensitivity_NN
to_TO
retinoic_JJ
acid_NN
-LRB-_-LRB-
RA_NN
-RRB-_-RRB-
-_:
induced_VBD
differentiation_NN
:_:
PML-RAR_NN
alpha_NN
blasts_NNS
are_VBP
sensitive_JJ
to_TO
RA_NN
and_CC
patients_NNS
enter_VBP
disease_NN
remission_NN
after_IN
RA_NN
treatment_NN
,_,
while_IN
patients_NNS
with_IN
PLZF-RAR_NN
alpha_NN
do_VBP
not_RB
._.

We_PRP
here_RB
report_VBP
that_IN
-LRB-_-LRB-
i_LS
-RRB-_-RRB-
like_IN
PML-RAR_NN
alpha_NN
expression_NN
,_,
PLZF-RAR_NN
alpha_NN
expression_NN
blocks_VBZ
terminal_JJ
differentiation_NN
of_IN
hematopoietic_JJ
precursor_NN
cell_NN
lines_NNS
-LRB-_-LRB-
U937_NN
and_CC
HL-60_NN
-RRB-_-RRB-
in_IN
response_NN
to_TO
different_JJ
stimuli_NNS
-LRB-_-LRB-
vitamin_NN
D3_NN
,_,
transforming_VBG
growth_NN
factor_NN
beta1_NN
,_,
and_CC
dimethyl_JJ
sulfoxide_NN
-RRB-_-RRB-
;_:
-LRB-_-LRB-
ii_LS
-RRB-_-RRB-
PML-RAR_NN
alpha_NN
,_,
but_CC
not_RB
PLZF-RAR_NN
alpha_NN
,_,
increases_VBZ
RA_NN
sensitivity_NN
of_IN
hematopoietic_JJ
precursor_NN
cells_NNS
and_CC
restores_VBZ
RA_NN
sensitivity_NN
of_IN
RA-resistant_JJ
hematopoietic_JJ
cells_NNS
;_:
-LRB-_-LRB-
iii_LS
-RRB-_-RRB-
PML-RAR_NN
alpha_NN
and_CC
PLZF-RAR_NN
alpha_NN
have_VBP
similar_JJ
RA_NN
binding_NN
affinities_NNS
;_:
and_CC
-LRB-_-LRB-
iv_LS
-RRB-_-RRB-
PML-RAR_NN
alpha_NN
enhances_VBZ
the_DT
RA_NN
response_NN
of_IN
RA_NN
target_NN
genes_NNS
-LRB-_-LRB-
those_DT
for_IN
RAR_NN
beta_NN
,_,
RAR_NN
gamma_NN
,_,
and_CC
transglutaminase_NN
type_NN
II_CD
-LCB-_-LRB-
TGase_NN
-RCB-_-RRB-
-RRB-_-RRB-
in_FW
vivo_FW
,_,
while_IN
PLZF-RAR_NN
alpha_NN
expression_NN
has_VBZ
either_CC
no_DT
effect_NN
-LRB-_-LRB-
RAR_NN
beta_NN
-RRB-_-RRB-
or_CC
an_DT
inhibitory_JJ
activity_NN
-LRB-_-LRB-
RAR_NN
gamma_NN
and_CC
type_NN
II_CD
TGase_NN
-RRB-_-RRB-
._.

These_DT
data_NNS
demonstrate_VBP
that_IN
PML-RAR_NN
alpha_NN
and_CC
PLZF-RAR_NN
alpha_NN
have_VBP
similar_JJ
-LRB-_-LRB-
inhibitory_JJ
-RRB-_-RRB-
effects_NNS
on_IN
RA-independent_JJ
differentiation_NN
and_CC
opposite_JJ
-LRB-_-LRB-
stimulatory_JJ
or_CC
inhibitory_JJ
-RRB-_-RRB-
effects_NNS
on_IN
RA-dependent_JJ
differentiation_NN
and_CC
that_IN
they_PRP
behave_VBP
in_FW
vivo_FW
as_IN
RA-dependent_JJ
enhancers_NNS
or_CC
inhibitors_NNS
of_IN
RA-responsive_JJ
genes_NNS
,_,
respectively_RB
._.

Their_PRP$
different_JJ
activities_NNS
on_IN
the_DT
RA_NN
signalling_NN
pathway_NN
might_MD
underlie_VB
the_DT
different_JJ
responses_NNS
of_IN
PML-RAR_NN
alpha_NN
and_CC
PLZF-RAR_NN
alpha_NN
APLs_NNS
to_TO
RA_NN
treatment_NN
._.

The_DT
PLZF-RAR_NN
alpha_NN
fusion_NN
protein_NN
contains_VBZ
an_DT
approximately_RB
120-amino-acid_JJ
N-terminal_JJ
motif_NN
-LRB-_-LRB-
called_VBN
the_DT
POZ_NN
domain_NN
-RRB-_-RRB-
,_,
which_WDT
is_VBZ
also_RB
found_VBN
in_IN
a_DT
variety_NN
of_IN
zinc_NN
finger_NN
proteins_NNS
and_CC
a_DT
group_NN
of_IN
poxvirus_NN
proteins_NNS
and_CC
which_WDT
mediates_VBZ
protein-protein_JJ
interactions_NNS
._.

Deletion_NN
of_IN
the_DT
PLZF_NN
POZ_NN
domain_NN
partially_RB
abrogated_VBD
the_DT
inhibitory_JJ
effect_NN
of_IN
PLZF-RAR_NN
alpha_NN
on_IN
RA-induced_JJ
differentiation_NN
and_CC
on_IN
RA-mediated_JJ
type_NN
II_CD
TGase_NN
up-regulation_NN
,_,
suggesting_VBG
that_IN
POZ-mediated_JJ
protein_NN
interactions_NNS
might_MD
be_VB
responsible_JJ
for_IN
the_DT
inhibitory_JJ
transcriptional_JJ
activities_NNS
of_IN
PLZF-RAR_NN
alpha_NN
._.

